Skip to main content
Signal8

Koppikar Utpal

SEC insider (Form 3/4/5 filer). CIK 0001742696. Director at INSMED Inc (INSM) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Oct 19, 2026. Located in BRIDGEWATER, NJ.

Companies Koppikar Utpal has filed insider reports for

  • INSMED Inc (INSM): Director
  • C4 Therapeutics, Inc. (CCCC): Director
Koppikar Utpal profile photo

Koppikar Utpal

CIK: 0001742696

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

INSMED Inc logo
INSM

INSMED Inc

Director
C4 Therapeutics, Inc. logo
CCCC

C4 Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • INSMED Inc logo
    INSM

    INSMED Inc

    Oct 19, 2026
    Award
    Direct
    6.1K shares-
  • C4 Therapeutics, Inc. logo
    CCCC

    C4 Therapeutics, Inc.

    Jun 24, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    62K shares-
  • C4 Therapeutics, Inc. logo
    CCCC

    C4 Therapeutics, Inc.

    Jun 18, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    35.5K shares-

1-3 of 3